Dan Burgess

Insider profile

Currently holds positions in Nabriva Therapeutics PLC, Santarus Inc, Cidara Therapeutics Inc and Arbutus Biopharma Corp

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Supervisory Board Nabriva Therapeutics PLC Oct. 1, 2016 -
Independent Director Santarus Inc July 1, 2004 -
Independent Director Cidara Therapeutics Inc April 1, 2014 -
Independent Director Arbutus Biopharma Corp March 23, 2017 -
Dan Burgess's trades of Nabriva Therapeutics PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-04 2022-08-02
S Sale
52,155 -21.4%
178.25
US$2,903,612 		52,155 -21.4% 178.25 US$2,903,612